Move forward with confidence.
Our cellular insights guide smarter preclinical decisions — helping you validate mechanisms, assess selectivity, and choose the right candidates to advance.
In-Vivo Target Engagement
Assess efficacy and safety before entering human trials.
Biomarker Discovery
Improve clinical success rates, treatment strategies, and contribute to better patient survival outcomes.
Translational Studies
Confirm target engagement across cell lines, animal tissues, and human-derived systems for reliable translational insights.
Why CETSA?
What makes CETSA different?
See CETSA in action
Explore our case stories.
Selectivity Profiling: Unbiased Analysis of Compound Selectivity in Drug Discovery
Join us for an in-depth webinar exploring how CETSA® Selectivity Profiling empowers smarter decision-making in drug discovery. Drew Nager will share how Pfizer Oncology leverages Pelago Bioscience’s C…
Novel Applications of the Cellular Thermal Shift Assay (CETSA) Provide New Insights for Drug Discovery
Join AbbVie scientists Shitalben Patel and Jami R. Erickson as they showcase their innovative advancements, transforming CETSA® into a high-throughput flow-based platform and introducing new whole blo…
Unbiased Selectivity Profiling: with CETSA® and Mass Spectrometry
Unbiased Selectivity Profiling: Revealing True Compound Specificity and Off-Target Interactions CETSA mass spectrometry profiling enables unbiased analysis of compound selectivity in drug discovery—he…